Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Molecular pathways involved in the improvement of non-alcoholic fatty liver disease.

Paz-Filho G, Mastronardi CA, Parker BJ, Khan A, Inserra A, Matthaei KI, Ehrhart-Bornstein M, Bornstein S, Wong ML, Licinio J.

J Mol Endocrinol. 2013 Jun 29;51(1):167-79. doi: 10.1530/JME-13-0072. Print 2013.

PMID:
23718963
2.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
3.

Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.

Bartelt A, Orlando P, Mele C, Ligresti A, Toedter K, Scheja L, Heeren J, Di Marzo V.

Diabetologia. 2011 Nov;54(11):2900-10. doi: 10.1007/s00125-011-2274-6. Epub 2011 Aug 17.

PMID:
21847582
5.

Brown Adipose Tissue Transplantation Reverses Obesity in Ob/Ob Mice.

Liu X, Wang S, You Y, Meng M, Zheng Z, Dong M, Lin J, Zhao Q, Zhang C, Yuan X, Hu T, Liu L, Huang Y, Zhang L, Wang D, Zhan J, Jong Lee H, Speakman JR, Jin W.

Endocrinology. 2015 Jul;156(7):2461-9. doi: 10.1210/en.2014-1598. Epub 2015 Apr 1.

PMID:
25830704
6.
7.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
8.

Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.

Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N.

J Biol Chem. 2002 May 31;277(22):19353-7. Epub 2002 Mar 28.

9.

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

Diabetes. 2006 Aug;55(8):2159-70.

10.

Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.

Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

J Pathol. 2006 Jan;208(1):74-81.

PMID:
16261527
11.

Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice.

de Oliveira CP, Stefano JT, de Lima VM, de Sá SV, Simplicio FI, de Mello ES, Corrêa-Giannella ML, Alves VA, Laurindo FR, de Oliveira MG, Giannella-Neto D, Carrilho FJ.

J Hepatol. 2006 Nov;45(5):725-33. Epub 2006 Jul 5.

PMID:
16935387
12.

Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.

Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.

PMID:
18794597
13.

Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge.

Paniagua JA, Escandell-Morales JM, Gil-Contreras D, Berral de la Rosa FJ, Romero-Jimenez M, Gómez-Urbano A, Sanchez-Lopez A, Bellido E, Poyato A, Calatayud B, Vidal-Puig AJ.

Nutrition. 2014 Feb;30(2):177-85. doi: 10.1016/j.nut.2013.07.017.

PMID:
24377452
14.

Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.

Perfield JW 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS.

J Obes. 2013;2013:296537. doi: 10.1155/2013/296537. Epub 2013 Jan 16.

15.

Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis.

Kuo JJ, Chang HH, Tsai TH, Lee TY.

Int J Mol Med. 2012 Sep;30(3):673-9. doi: 10.3892/ijmm.2012.1049. Epub 2012 Jun 29.

PMID:
22751848
16.

Lack of kinin B₁ receptor potentiates leptin action in the liver.

Fonseca RG, Sales VM, Ropelle E, Barros CC, Oyama L, Ihara SS, Saad MJ, Araújo RC, Pesquero JB.

J Mol Med (Berl). 2013 Jul;91(7):851-60. doi: 10.1007/s00109-013-1004-6. Epub 2013 Feb 6.

PMID:
23385644
17.

Fenretinide ameliorates insulin resistance and fatty liver in obese mice.

Koh IU, Jun HS, Choi JS, Lim JH, Kim WH, Yoon JB, Song J.

Biol Pharm Bull. 2012;35(3):369-75.

18.

Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.

Rhee SD, Kim CH, Park JS, Jung WH, Park SB, Kim HY, Bae GH, Kim TJ, Kim KY.

Eur J Pharmacol. 2012 Sep 15;691(1-3):9-18. doi: 10.1016/j.ejphar.2012.06.021. Epub 2012 Jun 26.

PMID:
22742899
19.

Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.

Shen L, Liu Z, Gong J, Zhang L, Wang L, Magdalou J, Chen L, Wang H.

Toxicol Appl Pharmacol. 2014 Jan 15;274(2):263-73. doi: 10.1016/j.taap.2013.11.009. Epub 2013 Nov 22.

PMID:
24275070
20.

Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity.

Foster MT, Shi H, Softic S, Kohli R, Seeley RJ, Woods SC.

Diabetologia. 2011 Nov;54(11):2890-9. doi: 10.1007/s00125-011-2259-5. Epub 2011 Jul 30.

Supplemental Content

Support Center